Low-dose vs. standard-dose alteplase for acute ischemic stroke: a retrospective cohort study of safety and efficacy in an Iranian population

Abstract Background The optimal dosing of alteplase for acute ischemic stroke remains debated, particularly regarding the balance between efficacy and bleeding risks. This study compared outcomes between standard-dose (0.9 mg/kg) and low-dose (< 0.85 mg/kg) alteplase in an Iranian cohort. Methods In...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Fatemeh Rahimi, Ashraf Zarvani, Farzad Fayedeh, Athena Sharifi-Razavi
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2025-09-01
Reeks:	BMC Neurology
Onderwerpen:	Stroke Alteplase dosing Thrombolytic therapy AIS
Online toegang:	https://doi.org/10.1186/s12883-025-04413-z
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!